US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
イギリス
LSE
Pharma Equity Group A/s (0REU)
Pharma Equity Group A/s (0REU) ニュース

0REU

Pharma Equity Group A/s (0REU)

Pharma Equity Group A/s

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:LSE:0REU

1

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/03	23 : 17	UK Regulatory	Results of extraordinary general meeting in Pharma Equity Group A/S	LSE:0REU	Pharma Equity Group A/s
2024/05/16	19 : 35	UK Regulatory	The Board of Director's decision to issue convertible loans	LSE:0REU	Pharma Equity Group A/s
2024/05/16	14 : 27	UK Regulatory	Consolidated interim report 1 January – 31 March 2024	LSE:0REU	Pharma Equity Group A/s
2024/05/08	22 : 16	UK Regulatory	Exploration of options regarding a directed capital increase at market price in Pharma Equity Group A/S	LSE:0REU	Pharma Equity Group A/s
2024/05/08	17 : 20	UK Regulatory	Notice convening the extraordinary general meeting of Pharma Equity Group A/S	LSE:0REU	Pharma Equity Group A/s
2024/04/23	18 : 45	UK Regulatory	Major shareholder announcement - Pharma Equity Group A/S	LSE:0REU	Pharma Equity Group A/s
2024/04/17	00 : 29	UK Regulatory	Passing of the General Meeting of Pharma Equity Group A/S	LSE:0REU	Pharma Equity Group A/s
2024/04/10	21 : 21	UK Regulatory	The Board of Director's decision to issue convertible loans	LSE:0REU	Pharma Equity Group A/s
2024/04/05	18 : 22	UK Regulatory	Pharma Equity Group’s subsidiary, Reponex Pharmaceuticals A/S, reports highly positive final results from the phase-2 clinical trial of the company’s patented drug candidate RNX-051.	LSE:0REU	Pharma Equity Group A/s
2024/03/25	21 : 06	UK Regulatory	Notice convening the annual general meeting in Pharma Equity Group A/S	LSE:0REU	Pharma Equity Group A/s
2024/03/22	17 : 00	UK Regulatory	Pharma Equity Group A/S (PEG) enters into an agreement with Danske Bank on the exercise of market maker in the PEG share, fund code: DK0061155009	LSE:0REU	Pharma Equity Group A/s
2024/03/22	00 : 32	UK Regulatory	Completion of subscription of convertible loans	LSE:0REU	Pharma Equity Group A/s
2024/03/20	16 : 58	UK Regulatory	Pharma Equity Group A/S - Annual Report 2023	LSE:0REU	Pharma Equity Group A/s
2024/03/05	18 : 11	UK Regulatory	Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has received notification from the European Patent Office (EPO) regarding the decision to grant their patent for drug compositions for promoting the healing of wounds (RNX-022).	LSE:0REU	Pharma Equity Group A/s
2024/02/07	21 : 38	UK Regulatory	Completion of subscription of convertible loans	LSE:0REU	Pharma Equity Group A/s
2024/02/07	17 : 46	UK Regulatory	The Board of Director's decision to issue convertible loans	LSE:0REU	Pharma Equity Group A/s
2024/01/25	18 : 08	UK Regulatory	Completion of subscription of convertible loans	LSE:0REU	Pharma Equity Group A/s

Showing the most relevant articles for your search:LSE:0REU

1

Invesco QQQ Trust Series 1

Energy Select Sector SPDR

Deutsche Telekom (QX)

JP Morgan Chase

Bank of America

Financial Select Sector

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約